According to their results, 38% of patients were prescribed at least one GO-PIMs, most-commonly selective serotonin reuptake inhibitors (SSRIs). Each additional GO-PIM was associated with a 66% ...
The details on the registration page are quite broad and they don’t show the duration of the event, nor a specific schedule of when individual topics will be covered. Even so, it may be worth ...
The researchers gave subjects challenging memory tests, including one called the backward digit span task, in which they would hear a list of up to nine digits and then try to repeat them in reverse ...
An unexpectedly wonderful dessert!This easy grape tart is a truly simple winter treat. It’s incredibly basic. All it is is shortcrust pastry pressed into a baking sheet and filled with halved grapes ...
These 2025 Damon Runyon cancer research fellows study bone-deep pain, bacterial secretions, re-engineered viruses, gamma delta T cells and more.
Stroke was the fourth leading cause in 2024, at 166,783 deaths. When combined with heart disease, cardiovascular causes are responsible for an overwhelming share of U.S. mortality. Despite ...
For Toni Moses, RN, a UCHealth emergency department nurse in Greeley, taking care of patients has been a profession and a passion for 34 years. She learned she had stage IV ovarian cancer in 2019, yet ...
See, I’m on a daily dose of steroids that we started during radiation therapy to help with the related edema. Headaches, for my presentation anyway, are the worst parts about brain swelling. The ...
Research by University of Colorado Cancer Center members at CSU’s Flint Animal Cancer Center could benefit both people and dogs. September 9, 2025 • By University of Colorado Cancer Center and Mark ...
In this first-person essay, author and writing coach Emily Rubin shares her shock and resolve regarding a second breast cancer diagnosis after many years in remission.
We round up national financial resources for people with cancer, including CancerCare, the HealthWell Foundation and Triage Cancer.
A single dose of psilocybin—the psychoactive compound in “magic mushrooms”—administered with psychological support continued to relieve depression and anxiety for two years in a small study of cancer ...